The U.S. ultraviolet disinfection equipment market size was USD 510 million in 2023, estimated at USD 580 million in 2024 and is anticipated to reach around USD 2,090 million by 2034, expanding at a CAGR of 14% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: US Ultraviolet Disinfection Equipment Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: US Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. US Ultraviolet Disinfection Equipment Market Revenue and Volume, by Component Type, 2024-2034
8.1.1 UV Lamps
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Ballasts/Controller Units
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Quartz Sleeves
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
8.1.4. Reactor Chambers
8.1.4.1. Market Revenue and Volume Forecast (2021-2034)
8.1.5. Others
8.1.5.1. Market Revenue and Volume Forecast (2021-2034)
9.1. US Ultraviolet Disinfection Equipment Market Revenue and Volume, by Application, 2024-2034
9.1.1. Water & Wastewater Treatment
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Air treatment
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Health facilities
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1.4. Residential and Commercial Buildings
9.1.4.1. Market Revenue and Volume Forecast (2021-2034)
9.1.5. Bio-Terror agents
9.1.5.1. Market Revenue and Volume Forecast (2021-2034)
9.1.6. Others
9.1.6.1. Market Revenue and Volume Forecast (2021-2034)
10.1. US Ultraviolet Disinfection Equipment Market Revenue and Volume, by End-use, 2024-2034
10.1.1. Municipal
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Residential
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1.3. Commercial
10.1.3.1. Market Revenue and Volume Forecast (2021-2034)
10.1.4. Industrial
10.1.4.1. Market Revenue and Volume Forecast (2021-2034)
11.1. U.S.
11.1.1. Market Revenue and Volume Forecast, by Component Type (2021-2034)
11.1.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.1. Xylem Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Atlantic Ultraviolet Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Evoqua Water Technologies LLC
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Trojan Technologies
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Halma PLC
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Kuraray Co., LTD
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Advanced UV, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. American Ultraviolet
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Atlantium Technologies LTD.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Hoenle AG
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client